Selected research
Market Structure
Global Point-of-care Testing Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Point-of-care Testing Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Point-of-care Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Point-of-care Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Point-of-care Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Point-of-care Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Point-of-care Testing Solution include Roche Diagnostics, Abbott, Johnson & Johnson, Siemens Healthineers, Danaher (Beckman Coulter), Ascensia, Sinocare, BioMérieux and QuidelOrtho, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Point-of-care Testing Solution market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Point-of-care Testing Solution and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Point-of-care Testing Solution sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Point-of-care Testing Solution market size, projected growth trends, production technologies, key applications, and end-use industries.
Point-of-care Testing Solution Segment by Company
Roche Diagnostics
Abbott
Johnson & Johnson
Siemens Healthineers
Danaher (Beckman Coulter)
Ascensia
Sinocare
BioMérieux
QuidelOrtho
BD
Nova Biomedical
Werfen
Chembio Diagnostics
Trinity Biotech
Thermo Fisher Scientific
SD Biosensor
Snibe Diagnostics
Wondfo
Yuwell
Runda Medical
Lepu Medical
Getein Biotech
Kehua Bio-engineering
Wuhan EasyDiagnosis Biomedicine
Anda Gene
Point-of-care Testing Solution Segment by Type
Electrochemical Type
Optical Type
Molecular Diagnostics Type
Point-of-care Testing Solution Segment by Application
Hospital
Clinic
R&D
Others
Point-of-care Testing Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-care Testing Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-care Testing Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-care Testing Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Point-of-care Testing Solution market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-care Testing Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Point-of-care Testing Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Point-of-care Testing Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Point-of-care Testing Solution Industry Trends
Table 2. Point-of-care Testing Solution Industry Drivers
Table 3. Point-of-care Testing Solution Industry Opportunities and Challenges
Table 4. Point-of-care Testing Solution Industry Restraints
Table 5. Global Point-of-care Testing Solution Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Point-of-care Testing Solution Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Point-of-care Testing Solution Sales by Manufacturers (k units) & (2021-2026)
Table 8. Global Point-of-care Testing Solution Sales Market Share by Manufacturers
Table 9. Global Point-of-care Testing Solution Average Sales Price (USD/unit) of Manufacturers (2021-2026)
Table 10. Global Point-of-care Testing Solution Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Point-of-care Testing Solution Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Point-of-care Testing Solution Manufacturers, Product Type & Application
Table 13. Global Point-of-care Testing Solution Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Point-of-care Testing Solution by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Electrochemical Type
Table 17. Major Manufacturers of Optical Type
Table 18. Major Manufacturers of Molecular Diagnostics Type
Table 19. Global Point-of-care Testing Solution Sales by Type 2021 VS 2025 VS 2032 (k units)
Table 20. Global Point-of-care Testing Solution Sales by Type (2021-2026) & (k units)
Table 21. Global Point-of-care Testing Solution Sales by Type (2027-2032) & (k units)
Table 22. Global Point-of-care Testing Solution Sales Market Share by Type (2021-2026)
Table 23. Global Point-of-care Testing Solution Sales Market Share by Type (2027-2032)
Table 24. Global Point-of-care Testing Solution Revenue by Type 2021 VS 2025 VS 2032 (k units)
Table 25. Global Point-of-care Testing Solution Revenue by Type (2021-2026) & (k units)
Table 26. Global Point-of-care Testing Solution Revenue by Type (2027-2032) & (k units)
Table 27. Global Point-of-care Testing Solution Revenue Market Share by Type (2021-2026)
Table 28. Global Point-of-care Testing Solution Revenue Market Share by Type (2027-2032)
Table 29. Major Manufacturers of Hospital
Table 30. Major Manufacturers of Clinic
Table 31. Major Manufacturers of R&D
Table 32. Major Manufacturers of Others
Table 33. Global Point-of-care Testing Solution Sales by Application 2021 VS 2025 VS 2032 (k units)
Table 34. Global Point-of-care Testing Solution Sales by Application (2021-2026) & (k units)
Table 35. Global Point-of-care Testing Solution Sales by Application (2027-2032) & (k units)
Table 36. Global Point-of-care Testing Solution Sales Market Share by Application (2021-2026)
Table 37. Global Point-of-care Testing Solution Sales Market Share by Application (2027-2032)
Table 38. Global Point-of-care Testing Solution Revenue by Application 2021 VS 2025 VS 2032 (k units)
Table 39. Global Point-of-care Testing Solution Revenue by Application (2021-2026) & (k units)
Table 40. Global Point-of-care Testing Solution Revenue by Application (2027-2032) & (k units)
Table 41. Global Point-of-care Testing Solution Revenue Market Share by Application (2021-2026)
Table 42. Global Point-of-care Testing Solution Revenue Market Share by Application (2027-2032)
Table 43. Global Point-of-care Testing Solution Sales by Region: 2021 VS 2025 VS 2032 (k units)
Table 44. Global Point-of-care Testing Solution Sales by Region (2021-2026) & (k units)
Table 45. Global Point-of-care Testing Solution Sales Market Share by Region (2021-2026)
Table 46. Global Point-of-care Testing Solution Sales Forecasted by Region (2027-2032) & (k units)
Table 47. Global Point-of-care Testing Solution Sales Forecasted Market Share by Region (2027-2032)
Table 48. North America Point-of-care Testing Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 49. North America Point-of-care Testing Solution Sales by Country (2021-2026) & (k units)
Table 50. North America Point-of-care Testing Solution Sales by Country (2027-2032) & (k units)
Table 51. Europe Point-of-care Testing Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 52. Europe Point-of-care Testing Solution Sales by Country (2021-2026) & (k units)
Table 53. Europe Point-of-care Testing Solution Sales by Country (2027-2032) & (k units)
Table 54. Asia Pacific Point-of-care Testing Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 55. Asia Pacific Point-of-care Testing Solution Sales by Country (2021-2026) & (k units)
Table 56. Asia Pacific Point-of-care Testing Solution Sales by Country (2027-2032) & (k units)
Table 57. South America, Middle East and Africa Point-of-care Testing Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 58. South America, Middle East and Africa Point-of-care Testing Solution Sales by Country (2021-2026) & (k units)
Table 59. South America, Middle East and Africa Point-of-care Testing Solution Sales by Country (2027-2032) & (k units)
Table 60. Global Point-of-care Testing Solution Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 61. Global Point-of-care Testing Solution Revenue by Region (2021-2026) & (US$ Million)
Table 62. Global Point-of-care Testing Solution Revenue by Region (2027-2032) & (US$ Million)
Table 63. Global Point-of-care Testing Solution Revenue Market Share by Region (2021-2026)
Table 64. Global Point-of-care Testing Solution Revenue Market Share by Region (2027-2032)
Table 65. Roche Diagnostics Company Information
Table 66. Roche Diagnostics Business Overview
Table 67. Roche Diagnostics Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Roche Diagnostics Point-of-care Testing Solution Product Portfolio
Table 69. Roche Diagnostics Recent Development
Table 70. Abbott Company Information
Table 71. Abbott Business Overview
Table 72. Abbott Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Abbott Point-of-care Testing Solution Product Portfolio
Table 74. Abbott Recent Development
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Johnson & Johnson Point-of-care Testing Solution Product Portfolio
Table 79. Johnson & Johnson Recent Development
Table 80. Siemens Healthineers Company Information
Table 81. Siemens Healthineers Business Overview
Table 82. Siemens Healthineers Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Siemens Healthineers Point-of-care Testing Solution Product Portfolio
Table 84. Siemens Healthineers Recent Development
Table 85. Danaher (Beckman Coulter) Company Information
Table 86. Danaher (Beckman Coulter) Business Overview
Table 87. Danaher (Beckman Coulter) Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Danaher (Beckman Coulter) Point-of-care Testing Solution Product Portfolio
Table 89. Danaher (Beckman Coulter) Recent Development
Table 90. Ascensia Company Information
Table 91. Ascensia Business Overview
Table 92. Ascensia Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Ascensia Point-of-care Testing Solution Product Portfolio
Table 94. Ascensia Recent Development
Table 95. Sinocare Company Information
Table 96. Sinocare Business Overview
Table 97. Sinocare Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Sinocare Point-of-care Testing Solution Product Portfolio
Table 99. Sinocare Recent Development
Table 100. BioMérieux Company Information
Table 101. BioMérieux Business Overview
Table 102. BioMérieux Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. BioMérieux Point-of-care Testing Solution Product Portfolio
Table 104. BioMérieux Recent Development
Table 105. QuidelOrtho Company Information
Table 106. QuidelOrtho Business Overview
Table 107. QuidelOrtho Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. QuidelOrtho Point-of-care Testing Solution Product Portfolio
Table 109. QuidelOrtho Recent Development
Table 110. BD Company Information
Table 111. BD Business Overview
Table 112. BD Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. BD Point-of-care Testing Solution Product Portfolio
Table 114. BD Recent Development
Table 115. Nova Biomedical Company Information
Table 116. Nova Biomedical Business Overview
Table 117. Nova Biomedical Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. Nova Biomedical Point-of-care Testing Solution Product Portfolio
Table 119. Nova Biomedical Recent Development
Table 120. Werfen Company Information
Table 121. Werfen Business Overview
Table 122. Werfen Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Werfen Point-of-care Testing Solution Product Portfolio
Table 124. Werfen Recent Development
Table 125. Chembio Diagnostics Company Information
Table 126. Chembio Diagnostics Business Overview
Table 127. Chembio Diagnostics Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Chembio Diagnostics Point-of-care Testing Solution Product Portfolio
Table 129. Chembio Diagnostics Recent Development
Table 130. Trinity Biotech Company Information
Table 131. Trinity Biotech Business Overview
Table 132. Trinity Biotech Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Trinity Biotech Point-of-care Testing Solution Product Portfolio
Table 134. Trinity Biotech Recent Development
Table 135. Thermo Fisher Scientific Company Information
Table 136. Thermo Fisher Scientific Business Overview
Table 137. Thermo Fisher Scientific Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. Thermo Fisher Scientific Point-of-care Testing Solution Product Portfolio
Table 139. Thermo Fisher Scientific Recent Development
Table 140. SD Biosensor Company Information
Table 141. SD Biosensor Business Overview
Table 142. SD Biosensor Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. SD Biosensor Point-of-care Testing Solution Product Portfolio
Table 144. SD Biosensor Recent Development
Table 145. Snibe Diagnostics Company Information
Table 146. Snibe Diagnostics Business Overview
Table 147. Snibe Diagnostics Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. Snibe Diagnostics Point-of-care Testing Solution Product Portfolio
Table 149. Snibe Diagnostics Recent Development
Table 150. Wondfo Company Information
Table 151. Wondfo Business Overview
Table 152. Wondfo Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 153. Wondfo Point-of-care Testing Solution Product Portfolio
Table 154. Wondfo Recent Development
Table 155. Yuwell Company Information
Table 156. Yuwell Business Overview
Table 157. Yuwell Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 158. Yuwell Point-of-care Testing Solution Product Portfolio
Table 159. Yuwell Recent Development
Table 160. Runda Medical Company Information
Table 161. Runda Medical Business Overview
Table 162. Runda Medical Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 163. Runda Medical Point-of-care Testing Solution Product Portfolio
Table 164. Runda Medical Recent Development
Table 165. Lepu Medical Company Information
Table 166. Lepu Medical Business Overview
Table 167. Lepu Medical Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 168. Lepu Medical Point-of-care Testing Solution Product Portfolio
Table 169. Lepu Medical Recent Development
Table 170. Getein Biotech Company Information
Table 171. Getein Biotech Business Overview
Table 172. Getein Biotech Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 173. Getein Biotech Point-of-care Testing Solution Product Portfolio
Table 174. Getein Biotech Recent Development
Table 175. Kehua Bio-engineering Company Information
Table 176. Kehua Bio-engineering Business Overview
Table 177. Kehua Bio-engineering Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 178. Kehua Bio-engineering Point-of-care Testing Solution Product Portfolio
Table 179. Kehua Bio-engineering Recent Development
Table 180. Wuhan EasyDiagnosis Biomedicine Company Information
Table 181. Wuhan EasyDiagnosis Biomedicine Business Overview
Table 182. Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 183. Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Product Portfolio
Table 184. Wuhan EasyDiagnosis Biomedicine Recent Development
Table 185. Anda Gene Company Information
Table 186. Anda Gene Business Overview
Table 187. Anda Gene Point-of-care Testing Solution Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 188. Anda Gene Point-of-care Testing Solution Product Portfolio
Table 189. Anda Gene Recent Development
Table 190. Key Raw Materials
Table 191. Raw Materials Key Suppliers
Table 192. Point-of-care Testing Solution Distributors List
Table 193. Point-of-care Testing Solution Customers List
Table 194. Research Programs/Design for This Report
Table 195. Authors List of This Report
Table 196. Secondary Sources
Table 197. Primary Sources
List of Figures
Figure 1. Point-of-care Testing Solution Product Image
Figure 2. Global Point-of-care Testing Solution Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Point-of-care Testing Solution Market Size (2021-2032) & (US$ Million)
Figure 4. Global Point-of-care Testing Solution Sales (2021-2032) & (k units)
Figure 5. Global Point-of-care Testing Solution Average Price (USD/unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Point-of-care Testing Solution Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Electrochemical Type Image
Figure 9. Optical Type Image
Figure 10. Molecular Diagnostics Type Image
Figure 11. Global Point-of-care Testing Solution Sales by Type (2021 VS 2025 VS 2032) & (k units)
Figure 12. Global Point-of-care Testing Solution Sales Market Share 2021 VS 2025 VS 2032
Figure 13. Global Point-of-care Testing Solution Sales Market Share by Type (2021-2032)
Figure 14. Global Point-of-care Testing Solution Revenue by Type (2021 VS 2025 VS 2032) & (k units)
Figure 15. Global Point-of-care Testing Solution Revenue Market Share 2021 VS 2025 VS 2032
Figure 16. Global Point-of-care Testing Solution Revenue Market Share by Type (2021-2032)
Figure 17. Hospital Image
Figure 18. Clinic Image
Figure 19. R&D Image
Figure 20. Others Image
Figure 21. Global Point-of-care Testing Solution Sales by Application (2021 VS 2025 VS 2032) & (k units)
Figure 22. Global Point-of-care Testing Solution Sales Market Share 2021 VS 2025 VS 2032
Figure 23. Global Point-of-care Testing Solution Sales Market Share by Application (2021-2032)
Figure 24. Global Point-of-care Testing Solution Revenue by Application (2021 VS 2025 VS 2032) & (k units)
Figure 25. Global Point-of-care Testing Solution Revenue Market Share 2021 VS 2025 VS 2032
Figure 26. Global Point-of-care Testing Solution Revenue Market Share by Application (2021-2032)
Figure 27. North America Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 28. North America Point-of-care Testing Solution Sales Market Share by Country (2021-2032)
Figure 29. U.S. Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 30. Canada Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 31. Mexico Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 32. Europe Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 33. Europe Point-of-care Testing Solution Sales Market Share by Country (2021-2032)
Figure 34. Germany Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 35. France Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 36. U.K. Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 37. Italy Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 38. Netherlands Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 39. Asia Pacific Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 40. Asia Pacific Point-of-care Testing Solution Sales Market Share by Country (2021-2032)
Figure 41. China Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 42. Japan Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 43. South Korea Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 44. Southeast Asia Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 45. India Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 46. Australia Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 47. South America, Middle East and Africa Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 48. South America, Middle East and Africa Point-of-care Testing Solution Sales Market Share by Country (2021-2032)
Figure 49. Brazil Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 50. South Africa Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 51. Saudi Arabia Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 52. Turkey Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 53. Argentina Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 54. UAE Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 55. Egypt Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 56. Chile Point-of-care Testing Solution Sales and Growth Rate (2021-2032) & (k units)
Figure 57. Global Point-of-care Testing Solution Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 58. Global Point-of-care Testing Solution Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 59. North America Point-of-care Testing Solution Revenue (2021-2032) & (US$ Million)
Figure 60. North America Point-of-care Testing Solution Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 61. Europe Point-of-care Testing Solution Revenue (2021-2032) & (US$ Million)
Figure 62. Europe Point-of-care Testing Solution Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 63. Asia-Pacific Point-of-care Testing Solution Revenue (2021-2032) & (US$ Million)
Figure 64. Asia-Pacific Point-of-care Testing Solution Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 65. South America, Middle East and Africa Point-of-care Testing Solution Revenue (2021-2032) & (US$ Million)
Figure 66. South America, Middle East and Africa Point-of-care Testing Solution Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 67. Point-of-care Testing Solution Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Point-of-care Testing Solution Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
Scope & coverage.
Types
- Electrochemical Type
- Optical Type
- Molecular Diagnostics Type
Applications
- Hospital
- Clinic
- R&D
- Others
Companies covered
- Roche Diagnostics
- Abbott
- Johnson & Johnson
- Siemens Healthineers
- Danaher (Beckman Coulter)
- Ascensia
- Sinocare
- BioMérieux
- QuidelOrtho
- BD
- Nova Biomedical
- Werfen
- Chembio Diagnostics
- Trinity Biotech
- Thermo Fisher Scientific
- SD Biosensor
- Snibe Diagnostics
- Wondfo
- Yuwell
- Runda Medical
- Lepu Medical
- Getein Biotech
- Kehua Bio-engineering
- Wuhan EasyDiagnosis Biomedicine
- Anda Gene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Point-of-care Testing Solution Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Point-of-care Testing Solution Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Point-of-care Testing Solution Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Point-of-care Testing Solution Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Point-of-care Testing Solution Market Dynamics
- 2.1 Point-of-care Testing Solution Industry Trends
- 2.2 Point-of-care Testing Solution Industry Drivers
- 2.3 Point-of-care Testing Solution Industry Opportunities and Challenges
- 2.4 Point-of-care Testing Solution Industry Restraints
3 Point-of-care Testing Solution Market by Manufacturers
- 3.1 Global Point-of-care Testing Solution Revenue by Manufacturers (2021-2026)
- 3.2 Global Point-of-care Testing Solution Sales by Manufacturers (2021-2026)
- 3.3 Global Point-of-care Testing Solution Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Point-of-care Testing Solution Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Point-of-care Testing Solution Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Point-of-care Testing Solution Manufacturers, Product Type & Application
- 3.7 Global Point-of-care Testing Solution Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Point-of-care Testing Solution Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Point-of-care Testing Solution Players Market Share by Revenue in 2025
- 3.8.3 2025 Point-of-care Testing Solution Tier 1, Tier 2, and Tier 3
4 Point-of-care Testing Solution Market by Type
- 4.1 Point-of-care Testing Solution Type Introduction
- 4.1.1 Electrochemical Type
- 4.1.2 Optical Type
- 4.1.3 Molecular Diagnostics Type
- 4.2 Global Point-of-care Testing Solution Sales by Type
- 4.2.1 Global Point-of-care Testing Solution Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Point-of-care Testing Solution Sales by Type (2021-2032)
- 4.2.3 Global Point-of-care Testing Solution Sales Market Share by Type (2021-2032)
- 4.3 Global Point-of-care Testing Solution Revenue by Type
- 4.3.1 Global Point-of-care Testing Solution Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Point-of-care Testing Solution Revenue by Type (2021-2032)
- 4.3.3 Global Point-of-care Testing Solution Revenue Market Share by Type (2021-2032)
5 Point-of-care Testing Solution Market by Application
- 5.1 Point-of-care Testing Solution Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 R&D
- 5.1.4 Others
- 5.2 Global Point-of-care Testing Solution Sales by Application
- 5.2.1 Global Point-of-care Testing Solution Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Point-of-care Testing Solution Sales by Application (2021-2032)
- 5.2.3 Global Point-of-care Testing Solution Sales Market Share by Application (2021-2032)
- 5.3 Global Point-of-care Testing Solution Revenue by Application
- 5.3.1 Global Point-of-care Testing Solution Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Point-of-care Testing Solution Revenue by Application (2021-2032)
- 5.3.3 Global Point-of-care Testing Solution Revenue Market Share by Application (2021-2032)
6 Global Point-of-care Testing Solution Sales by Region
- 6.1 Global Point-of-care Testing Solution Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Point-of-care Testing Solution Sales by Region (2021-2032)
- 6.2.1 Global Point-of-care Testing Solution Sales by Region (2021-2026)
- 6.2.2 Global Point-of-care Testing Solution Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Point-of-care Testing Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Point-of-care Testing Solution Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Point-of-care Testing Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Point-of-care Testing Solution Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Point-of-care Testing Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Point-of-care Testing Solution Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Point-of-care Testing Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Point-of-care Testing Solution Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Point-of-care Testing Solution Revenue by Region
- 7.1 Global Point-of-care Testing Solution Revenue by Region
- 7.1.1 Global Point-of-care Testing Solution Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Point-of-care Testing Solution Revenue by Region (2021-2026)
- 7.1.3 Global Point-of-care Testing Solution Revenue by Region (2027-2032)
- 7.1.4 Global Point-of-care Testing Solution Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Point-of-care Testing Solution Revenue (2021-2032)
- 7.2.2 North America Point-of-care Testing Solution Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Point-of-care Testing Solution Revenue (2021-2032)
- 7.3.2 Europe Point-of-care Testing Solution Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Point-of-care Testing Solution Revenue (2021-2032)
- 7.4.2 Asia-Pacific Point-of-care Testing Solution Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Point-of-care Testing Solution Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Point-of-care Testing Solution Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Roche Diagnostics
- 8.1.1 Roche Diagnostics Company Information
- 8.1.2 Roche Diagnostics Business Overview
- 8.1.3 Roche Diagnostics Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Roche Diagnostics Point-of-care Testing Solution Product Portfolio
- 8.1.5 Roche Diagnostics Recent Developments
- 8.2 Abbott
- 8.2.1 Abbott Company Information
- 8.2.2 Abbott Business Overview
- 8.2.3 Abbott Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Abbott Point-of-care Testing Solution Product Portfolio
- 8.2.5 Abbott Recent Developments
- 8.3 Johnson & Johnson
- 8.3.1 Johnson & Johnson Company Information
- 8.3.2 Johnson & Johnson Business Overview
- 8.3.3 Johnson & Johnson Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Johnson & Johnson Point-of-care Testing Solution Product Portfolio
- 8.3.5 Johnson & Johnson Recent Developments
- 8.4 Siemens Healthineers
- 8.4.1 Siemens Healthineers Company Information
- 8.4.2 Siemens Healthineers Business Overview
- 8.4.3 Siemens Healthineers Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Siemens Healthineers Point-of-care Testing Solution Product Portfolio
- 8.4.5 Siemens Healthineers Recent Developments
- 8.5 Danaher (Beckman Coulter)
- 8.5.1 Danaher (Beckman Coulter) Company Information
- 8.5.2 Danaher (Beckman Coulter) Business Overview
- 8.5.3 Danaher (Beckman Coulter) Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Danaher (Beckman Coulter) Point-of-care Testing Solution Product Portfolio
- 8.5.5 Danaher (Beckman Coulter) Recent Developments
- 8.6 Ascensia
- 8.6.1 Ascensia Company Information
- 8.6.2 Ascensia Business Overview
- 8.6.3 Ascensia Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Ascensia Point-of-care Testing Solution Product Portfolio
- 8.6.5 Ascensia Recent Developments
- 8.7 Sinocare
- 8.7.1 Sinocare Company Information
- 8.7.2 Sinocare Business Overview
- 8.7.3 Sinocare Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Sinocare Point-of-care Testing Solution Product Portfolio
- 8.7.5 Sinocare Recent Developments
- 8.8 BioMérieux
- 8.8.1 BioMérieux Company Information
- 8.8.2 BioMérieux Business Overview
- 8.8.3 BioMérieux Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 BioMérieux Point-of-care Testing Solution Product Portfolio
- 8.8.5 BioMérieux Recent Developments
- 8.9 QuidelOrtho
- 8.9.1 QuidelOrtho Company Information
- 8.9.2 QuidelOrtho Business Overview
- 8.9.3 QuidelOrtho Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 QuidelOrtho Point-of-care Testing Solution Product Portfolio
- 8.9.5 QuidelOrtho Recent Developments
- 8.10 BD
- 8.10.1 BD Company Information
- 8.10.2 BD Business Overview
- 8.10.3 BD Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 BD Point-of-care Testing Solution Product Portfolio
- 8.10.5 BD Recent Developments
- 8.11 Nova Biomedical
- 8.11.1 Nova Biomedical Company Information
- 8.11.2 Nova Biomedical Business Overview
- 8.11.3 Nova Biomedical Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Nova Biomedical Point-of-care Testing Solution Product Portfolio
- 8.11.5 Nova Biomedical Recent Developments
- 8.12 Werfen
- 8.12.1 Werfen Company Information
- 8.12.2 Werfen Business Overview
- 8.12.3 Werfen Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Werfen Point-of-care Testing Solution Product Portfolio
- 8.12.5 Werfen Recent Developments
- 8.13 Chembio Diagnostics
- 8.13.1 Chembio Diagnostics Company Information
- 8.13.2 Chembio Diagnostics Business Overview
- 8.13.3 Chembio Diagnostics Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Chembio Diagnostics Point-of-care Testing Solution Product Portfolio
- 8.13.5 Chembio Diagnostics Recent Developments
- 8.14 Trinity Biotech
- 8.14.1 Trinity Biotech Company Information
- 8.14.2 Trinity Biotech Business Overview
- 8.14.3 Trinity Biotech Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Trinity Biotech Point-of-care Testing Solution Product Portfolio
- 8.14.5 Trinity Biotech Recent Developments
- 8.15 Thermo Fisher Scientific
- 8.15.1 Thermo Fisher Scientific Company Information
- 8.15.2 Thermo Fisher Scientific Business Overview
- 8.15.3 Thermo Fisher Scientific Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Thermo Fisher Scientific Point-of-care Testing Solution Product Portfolio
- 8.15.5 Thermo Fisher Scientific Recent Developments
- 8.16 SD Biosensor
- 8.16.1 SD Biosensor Company Information
- 8.16.2 SD Biosensor Business Overview
- 8.16.3 SD Biosensor Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 SD Biosensor Point-of-care Testing Solution Product Portfolio
- 8.16.5 SD Biosensor Recent Developments
- 8.17 Snibe Diagnostics
- 8.17.1 Snibe Diagnostics Company Information
- 8.17.2 Snibe Diagnostics Business Overview
- 8.17.3 Snibe Diagnostics Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Snibe Diagnostics Point-of-care Testing Solution Product Portfolio
- 8.17.5 Snibe Diagnostics Recent Developments
- 8.18 Wondfo
- 8.18.1 Wondfo Company Information
- 8.18.2 Wondfo Business Overview
- 8.18.3 Wondfo Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Wondfo Point-of-care Testing Solution Product Portfolio
- 8.18.5 Wondfo Recent Developments
- 8.19 Yuwell
- 8.19.1 Yuwell Company Information
- 8.19.2 Yuwell Business Overview
- 8.19.3 Yuwell Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Yuwell Point-of-care Testing Solution Product Portfolio
- 8.19.5 Yuwell Recent Developments
- 8.20 Runda Medical
- 8.20.1 Runda Medical Company Information
- 8.20.2 Runda Medical Business Overview
- 8.20.3 Runda Medical Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Runda Medical Point-of-care Testing Solution Product Portfolio
- 8.20.5 Runda Medical Recent Developments
- 8.21 Lepu Medical
- 8.21.1 Lepu Medical Company Information
- 8.21.2 Lepu Medical Business Overview
- 8.21.3 Lepu Medical Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Lepu Medical Point-of-care Testing Solution Product Portfolio
- 8.21.5 Lepu Medical Recent Developments
- 8.22 Getein Biotech
- 8.22.1 Getein Biotech Company Information
- 8.22.2 Getein Biotech Business Overview
- 8.22.3 Getein Biotech Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 Getein Biotech Point-of-care Testing Solution Product Portfolio
- 8.22.5 Getein Biotech Recent Developments
- 8.23 Kehua Bio-engineering
- 8.23.1 Kehua Bio-engineering Company Information
- 8.23.2 Kehua Bio-engineering Business Overview
- 8.23.3 Kehua Bio-engineering Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.23.4 Kehua Bio-engineering Point-of-care Testing Solution Product Portfolio
- 8.23.5 Kehua Bio-engineering Recent Developments
- 8.24 Wuhan EasyDiagnosis Biomedicine
- 8.24.1 Wuhan EasyDiagnosis Biomedicine Company Information
- 8.24.2 Wuhan EasyDiagnosis Biomedicine Business Overview
- 8.24.3 Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.24.4 Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Product Portfolio
- 8.24.5 Wuhan EasyDiagnosis Biomedicine Recent Developments
- 8.25 Anda Gene
- 8.25.1 Anda Gene Company Information
- 8.25.2 Anda Gene Business Overview
- 8.25.3 Anda Gene Point-of-care Testing Solution Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.25.4 Anda Gene Point-of-care Testing Solution Product Portfolio
- 8.25.5 Anda Gene Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Point-of-care Testing Solution Value Chain Analysis
- 9.1.1 Point-of-care Testing Solution Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Point-of-care Testing Solution Production Mode & Process
- 9.2 Point-of-care Testing Solution Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Point-of-care Testing Solution Distributors
- 9.2.3 Point-of-care Testing Solution Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst